Does TOFACITINIB Cause Dementia? 334 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 334 reports of Dementia have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.2% of all adverse event reports for TOFACITINIB.
334
Reports of Dementia with TOFACITINIB
0.2%
of all TOFACITINIB reports
29
Deaths
54
Hospitalizations
How Dangerous Is Dementia From TOFACITINIB?
Of the 334 reports, 29 (8.7%) resulted in death, 54 (16.2%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Dementia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 334 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Dementia?
APIXABAN (1,459)
PIMAVANSERIN (1,116)
CARBIDOPA\LEVODOPA (854)
LENALIDOMIDE (651)
SACUBITRIL\VALSARTAN (450)
INSULIN GLARGINE (438)
ADALIMUMAB (401)
INSULIN LISPRO (375)
RIVASTIGMINE (337)
PREGABALIN (319)
Which TOFACITINIB Alternatives Have Lower Dementia Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN